Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 660

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 660
---
 adjustment in the unaudited pro forma condensed combined statement of operations for the twelve months ended December 31, 2023.

DDRelated to the Kintara Merger, reflects the Legacy TuHURA reversal of interest expense incurred on the Notes for the year ended December 31, 2023 of $18,688.

EEReflects estimated transaction costs related to the Mergers in the amount of $6,155,321 which is comprised of $1,755,321 of costs expected to be incurred by Kineta and $4,400,000 of costs expected**

<div align='center'>428</div>

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION to be incurred by TuHURA subsequent to September 30, 2024 that are expected to be directly attributable to the Mergers (refer to adjustments I1and I2), including the following: (i) One-timespecial bonus and additional severance costs incurred by Kineta upon the Closing of the Mergers in the amount of $825,321; (ii) Estimated costs to be incurred by Kineta of $930,000, consisting of additional transaction-related expenses expected between September 30, 2024 and the Closing, primarily relating to legal and other professional fees. (iii) Estimated costs to be incurred by TuHURA of $4,400,000, consisting of additional transaction-related expenses expected between September 30, 2024 and closing, primarily relating to printing, legal and other professional fees. As the above costs all represent the estimate of one-timeexpenses directly attributable to the Mergers, and the unaudited pro forma condensed combined statements of operations give pro forma effect to the Mergers as if the Mergers had occurred on January 1, 2023, all $6,155,321 are presented as adjustments to general and administrative expenses in the unaudited pro forma condensed combined statement of operations for the twelve months ended December 31, 2023. Note 5. Net Loss per Share Net loss per share was first calculated for the already completed Kintara Merger using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Kintara Merger, assuming the shares were outstanding since January 1, 2023. As the Kintara Merger is being reflected as if it had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic